A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years

被引：8

作者：

Patruno, Cataldo ^{[1
]}

Fabbrocini, Gabriella ^{[2
]}

Lauletta, Giuseppe ^{[2
]}

Boccaletti, Valeria ^{[3
]}

Colonna, Cristiana ^{[4
]}

Cavalli, Riccardo ^{[4
]}

Neri, Iria ^{[5
]}

Ortoncelli, Michela ^{[6
]}

Schena, Donatella ^{[7
]}

Stingeni, Luca ^{[8
]}

Hansel, Katharina ^{[8
]}

Piccolo, Vincenzo ^{[9
]}

Di Brizzi, Veronica ^{[9
]}

Potenza, Concetta ^{[10
]}

Tolino, Ersilia ^{[10
]}

Bianchi, Luca ^{[11
]}

Manti, Sara ^{[11
]}

De Pasquale, Rocco ^{[12
]}

Di Lernia, Vito ^{[13
]}

Caminiti, Lucia ^{[14
]}

Galli, Elena ^{[15
]}

Coppo, Paola ^{[16
]}

Chiricozzi, Andrea ^{[17
,18
]}

De Simone, Clara ^{[17
,18
]}

Guerriero, Cristina ^{[17
]}

Amoruso, Fabrizio Giuseppe ^{[19
]}

Provenzano, Eugenio ^{[19
]}

Leonardi, Salvatore ^{[20
]}

Licari, Amelia ^{[21
]}

Marseglia, Gian Luigi ^{[21
]}

Palermo, Antonino ^{[22
]}

Di Pillo, Sabrina ^{[23
]}

Russo, Daniele ^{[23
]}

Moschese, Viviana ^{[24
]}

Patella, Vincenzo ^{[25
]}

Peduto, Tiziana ^{[25
]}

Ferreli, Caterina ^{[26
]}

Zangari, Paola ^{[27
]}

Veronese, Federica ^{[28
]}

Berti, Samantha Federica ^{[29
]}

Gruber, Michaela ^{[30
]}

Pezzolo, Elena ^{[31
]}

Termine, Stefania ^{[32
]}

Satta, Rosanna ^{[33
]}

Dragoni, Federica ^{[34
]}

Esposito, Maria ^{[35
]}

Fargnoli, Maria Concetta ^{[35
]}

Chiodini, Paolo ^{[9
]}

Vallone, Ylenia ^{[2
]}

di Vico, Francesca ^{[2
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy

[2] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy

[3] Univ Brescia, Dept Med, Sect Dermatol, Brescia, Italy

[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Clin Sci & Community Hlth, Pediat Dermatol Unit, Milan, Italy

[5] Univ Bologna, Unit Dermatol, IRCCS AOU Policlin S Orsola, Bologna, Italy

[6] Univ Turin, Dept Med Sci, Div Dermatol, Turin, Italy

[7] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy

[8] Univ Perugia, Dept Med & Surg, Dermatol Sect, Perugia, Italy

[9] Univ Campania Luigi Vanvitelli, Dermatol Unit, Caserta, Italy

[10] Sapienza Univ Rome, Dept Med Surg Sci & Biotechnol, Dermatol Unit Daniele Innocenzi, Polo Pontino, Latina, Italy

[11] Univ Tor Vergata, Syst Med Dept, Dermatol Unit, Policlin Tor Vergata, Rome, Italy

[12] Osped San Marco, UO Dermatol, Catania, Italy

[13] Azienda USL IRCCS Reggio Emilia, Dermatol Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

[14] Univ Messina, Policlin Hosp, Messina, Italy

[15] Osped San Pietro Fatebenefratelli, UOS Immuno Allergol Eta evolut, Rome, Italy

[16] Regina Margher Childrens Hosp Citta Salute & Sci T, Pediat Endocrinol Unit, Turin, Italy

[17] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, Rome, Italy

[18] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslazionale, Dermatol, Rome, Italy

[19] Azienda Osped Cosenza, Dermatol Unit, Cosenza, Italy

[20] Univ Catania, San Marco Hosp, Dept Clin & Expt Med, Pediat Resp Unit, Catania, Italy

[21] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Pediat, Pediat Clin, Pavia, Italy

[22] Garibaldi Hosp, Dept Pediat, Catania, Italy

[23] Univ G dAnnunzio, Dept Pediat, Pediat Allergy & Pulmonol Unit, Chieti, Italy

[24] Univ Roma Tor Vergata, Pediat Allergol & Immunol Unit, Policlin Tor Vergata, Rome, Italy

[25] Santa Maria Speranza Hosp, Dept Med, Div Allergy & Clin Immunol, Battipaglia, SA, Italy

[26] Univ Cagliari, Dept Med Sci & Publ Hlth, Dermatol Clin, Cagliari, Italy

[27] Bambino Gesu Pediat Hosp, Acad Dept Pediat DPUO, Res Unit Clin Immunol & Vaccinol, IRCCS, Rome, Italy

[28] AOU Maggiore Car Hosp, Dermatol Clin, Novara, Italy

[29] Univ Florence, Dept Surg & Translat Med, Dermatol Unit, Florence, Italy

[30] Cent Hosp Bolzano, Dept Pediat, Bolzano, Italy

[31] Osped San Bortolo, Dermatol Unit, Vicenza, Italy

[32] Santa Chiara Hosp, Div Dermatol, Trento, Italy

[33] Univ Sassari, Dipartimento Sci Med Chirurg & Sperimentali, Sassari, Italy

[34] UOC Dermatol Osped San Donato, Arezzo, Italy

[35] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Dermatol, Laquila, Italy

来源：

JOURNAL OF DERMATOLOGICAL TREATMENT | 2023年 / 34卷 / 01期

关键词：

Atopic dermatitis; children; dupilumab; real-world data;

D O I：

10.1080/09546634.2023.2246602

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background: Dupilumab has been shown to be a safe and effective drug for the treatment of atopic dermatitis (AD) in children from 6 months to 11 years in randomized clinical trials. Aim: The aim of this real-life study was to determine the effectiveness in disease control and safety of dupilumab at W52 in moderate-to-severe AD children aged 6-11 years. Methods: All data were collected from 36 Italian dermatological or paediatric referral centres. Dupilumab was administered at label dosage with an induction dose of 300 mg on day 1 (D1), followed by 300 mg on D15 and 300 mg every 4 weeks (Q4W). Treatment effect was determined as overall disease severity, using EASI, P-NRS, S-NRS and c-DLQI at baseline, W16, W24, and W52. Ninety-six AD children diagnosed with moderate-to-severe AD and treated with dupilumab were enrolled. Results: Ninety-one (94.8%) patients completed the 52-week treatment period and were included in the study. A significant improvement in EASI score, P-NRS, S-NRS and c-DLQI was observed from baseline to weeks 16, 24 and 52. Conclusions: Our real-life data seem to confirm dupilumab effectiveness and safety in paediatric patients. Moreover, our experience highlighted that patients achieving clinical improvement at W16 preserved this condition over time.

引用

页数：6

共 50 条

[21] Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China
Deng, Sisi
Wang, Huan
Chen, Qiquan
Chen, Xueqin
Song, Xiao
Chen, Shuguang
Kong, Minmin
Song, Zhiqiang
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
[22] Drug survival of secukinumab in real-world plaque psoriasis patients: A 52-week, multicenter, retrospective study
Georgakopoulos, Jorge R.
Ighani, Arvin
Phung, Michelle
Yeung, Jensen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (05) : 1019 - 1020
[23] Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
Jang, Dong Hyek
Heo, Seok Jae
Jung, Hye Jung
Park, Mi Yeon
Seo, Seong Jun
Ahn, Jiyoung
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 12
[24] Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: A multi centric retrospective study
Dhar, Sandipan
De, Abhishek
Srinivas, Sahana M.
INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (03) : 297 - 301
[25] Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
Zhou, Bingjing
Peng, Cong
Li, Liqiao
Liu, Runqiu
Zhu, Lei
Chen, Xiang
Li, Jie
FRONTIERS IN MEDICINE, 2022, 9
[26] Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practice
Lasek, A.
Bellon, N.
Mallet, S.
Puzenat, E.
Bursztejn, A. C.
Abasq, C.
Mazereeuw-Hautier, J.
Chiaverini, C.
Hubiche, T.
Raison Peyron, N.
Du Thanh, A.
Barbarot, S.
Aubert, H.
Reguiai, Z.
Droitcourt, C.
Fievet, C.
Bellissen, A.
Bachelerie, M.
Nosbaum, A.
Leymarie, A.
Armingaud, P.
Masson Regnault, M.
Mahe, E.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (12) : 2423 - 2429
[27] Effectiveness and safety of dupilumab in moderate-to-severe atopic dermatitis patients with chronic renal insufficiency: a real-world retrospective study in China
Peng, Cong
Cao, Qiaozhi
Xiong, Feng
Xu, Hui
Li, Jie
MEDCOMM, 2024, 5 (10):
[28] Use of Dupilumab for Adult-Onset Atopic Dermatitis: A Real-World Retrospective Study
Sood, Siddhartha
Georgakopoulos, Jorge R.
Maliyar, Khalad
Sachdeva, Muskaan
Mufti, Asfandyar
Yeung, Jensen
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (01) : 96 - 97
[29] Benefits of treatment with dupilumab for children aged 6-11 years with severe atopic dermatitis
不详
BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (02) : E39 - E39
[30] Predictive features for effectiveness of dupilumab in elderly patients with atopic dermatitis: a real-world study
Jia, Qiqi
Cao, Qiaozhi
Peng, Cong
Shui, Xinyu
Li, Jie
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (05) : 848 - 850

← 1 2 3 4 5 →